Patent Oppositions in medical and personal care products industry

Explore the competitive field of medical and personal care products where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in medical and personal care products technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Last updated on: Jul 9, 2026
CompanyTotal Oppositions
NOVARTIS342
BOEHRINGER INGELHEIM170
NUTRICIA133
GLAXOSMITHKLINE114
NOVO NORDISK112
AMGEN108
PFIZER92
F HOFFMANN LA ROCHE88
NESTLE82
CELGENE72

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the medical and personal care products industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the medical and personal care products industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jul 9, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Compositions And Methods For Internalizing EnzymesREGENERON PHARMACEUTICALSJun 3, 2026SANOFI
Rimegepant For Cgrp Related DisordersPFIZERMay 28, 2026BARDEHLE PAGENBERG
Compositions And Methods For Internalizing EnzymesREGENERON PHARMACEUTICALSMay 27, 2026HAMPTON KNOWLES
Sotorasib Dosing RegimenAMGENMay 26, 2026BOTTI & FERRARI
Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-DioneAMGEN EUROPEMay 20, 2026SANDOZ
Methods Of Treating Hfpef Employing Dapagliflozin And Compositions Comprising The SameASTRAZENECAMay 20, 2026AWA DENMARK
Composition For Inducing Proliferation Or Accumulation Of Regulatory T CellsTHE UNIVERSITY OF TOKYOMay 20, 2026RIECK
Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-DioneAMGEN EUROPEMay 19, 2026KELTIE
Beta-1,3'-Galactosyllactose For The Treatment Of Gut Barrier Function DiseasesNUTRICIAMay 19, 2026SOCIT DES PRODUITS NESTL
Composition For Inducing Proliferation Or Accumulation Of Regulatory T CellsTHE UNIVERSITY OF TOKYOMay 19, 2026NESTLE

To stay ahead in the competitive medical and personal care products industry, companies are constantly innovating. Here are the top patents facing oppositions in the medical and personal care products industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jul 9, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Oct 12, 2022S1P Receptor Modulators For Treating Multiple SclerosisNOVARTIS26
Apr 14, 2021Methods And Compositions For Treating CancerCOUGAR BIOTECHNOLOGY24
Nov 6, 2024Dosing Regimen Associated With Long Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICA23
Oct 23, 2024New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTIS20
Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM19
Oct 11, 2023New UseNOVARTIS19
Aug 6, 2025Use Of Long-Acting Glp-1 PeptidesNOVO NORDISK18
Mar 8, 2023Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTIS18
Jan 16, 2019(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions ThereofCELGENE17
Mar 10, 2021Novel Antitumoral Use Of CabazitaxelSANOFI15